Current Problems in Cardiology
Volume 33, Issue 11 , Pages 629-694 , November 2008

Long QT Syndrome

References 

  1. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: a prospective international study. Circulation. 1985;71:17–21
  2. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome (Prospective longitudinal study of 328 families). Circulation. 1991;84:1136–1144
  3. Tester DJ, Will ML, Haglund CM, et al. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005;2:507–517
  4. Spooner PM, Albert C, Benjamin EJ, et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation. 2001;103:2361–2364
  5. Jervell A, Lange-Nielsen F. Congenital deal-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54:59–68
  6. Levine SA, Woodworth CR. Congenital deaf-mutism, prolonged QT interval, syncopal attacks and sudden death. N Engl J Med. 1958;259:412–417
  7. Jervell A. The surdo-cardiac syndrome. Eur Heart J. 1985;6(suppl D):97–102
  8. Splawski I, Timothy KW, Vincent GM, et al. Molecular basis of the long-QT syndrome associated with deafness. [see comments] N Engl J Med. 1997;336:1562–1567
  9. Romano C, Gemme G, Pongiglione R. Rare cardiac arrythmias of the pediatric age (Ii syncopal attacks due to paroxysmal ventricular fibrillation). (Presentation of 1st case in Italian pediatric Literature.) Clin Pediatr (Bologna). 1963;45:656–683
  10. Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc. 1964;54:103–106
  11. Yanowitz F, Preston JB, Abildskov JA. Functional distribution of right and left stellate innervation to the ventricles (Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone). Circ Res. 1966;18:416–428
  12. Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285:903–904
  13. Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826–1833
  14. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616–623
  15. Schwartz PJ, Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J. 1975;89:45–50
  16. Crampton RS. Another link between the left stellate ganglion and the long Q-T syndrome. Am Heart J. 1978;96:130–132
  17. Moss AJ, Schwartz PJ. 25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. Circulation. 2005;111:1199–1201
  18. Moss AJ, Kass RS. Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest. 2005;115:2018–2024
  19. Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell. 2001;105:511–519
  20. Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19–31
  21. Medeiros-Domingo A, Kaku T, Tester DJ, et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation. 2007;116:134–142
  22. Schott J-JMP, Gramolini AO. Mutation in the ankyrin-B gene causes Long QT syndrome and sinus node dysfunction. Circulation. 2002;106:II-308
  23. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature. 2003;421:634–639
  24. Vatta M, Ackerman MJ, Ye B, et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation. 2006;114:2104–2112
  25. Cronk LB, Ye B, Kaku T, et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm. 2007;4:161–166
  26. Anderson CL, Delisle BP, Anson BD, et al. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation. 2006;113:365–373
  27. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. [see comments] Circulation. 1995;92:2929–2934
  28. Moss AJ, Robinson JL. Long QT syndrome. Heart Dis Stroke. 1992;1:309–314
  29. Lehnart SE, Ackerman MJ, Benson DW, et al. Inherited arrhythmias (A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function). Circulation. 2007;116:2325–2345
  30. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8:690–695
  31. Vincent GM, Timothy KW, Leppert M, et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846–852
  32. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med. 1998;338:1709–1714
  33. Malfatto G, Beria G, Sala S, et al. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol. 1994;23:296–301
  34. Lehmann MH, Suzuki F, Fromm BS, et al. T wave “humps” as a potential electrocardiographic marker of the long QT syndrome. J Am Coll Cardiol. 1994;24:746–754
  35. Zareba W, Moss AJ, le Cessie S, et al. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994;23:1541–1546
  36. Zhang L, Timothy KW, Vincent GM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000;102:2849–2855
  37. Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88:782–784
  38. Tester DJ, Will ML, Haglund CM, et al. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006;47:764–768
  39. Krahn AD, Klein GJ, Yee R. Hysteresis of the RT interval with exercise: a new marker for the long-QT syndrome?. Circulation. 1997;96:1551–1556
  40. Takenaka K, Tomohiko A, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation. 2003;107:838–844
  41. Nemec J, Buncova M, Bulkova V, et al. Heart rate dependence of the QT interval duration: differences among congenital long QT syndrome subtypes. J Cardiovasc Electrophysiol. 2004;15:550–556
  42. Couderc JP, Vaglio M, Cia X, et al. Impaired T-amplitude adaptation to heart rate characterizes IKr inhibition in the congenital and acquired forms of the long QT syndrome. J Cardiovasc Electrophysiol. 2007;18:1299–1305
  43. Kaufman ES, Priori SG, Napolitano C, et al. Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol. 2001;12:455–461
  44. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol. 2002;17:43–51
  45. Noda T, Takaki H, Kurita T, et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J. 2002;23:975–983
  46. Ackerman MJ, Khositseth A, Tester DJ, et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc. 2002;77:413–421
  47. Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm. 2004;1:276–283
  48. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome (International Long-QT Syndrome Registry Research Group). N Engl J Med. 1998;339:960–965
  49. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866–1874
  50. Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with β-blockers. JAMA. 2004;292:1341–1344
  51. Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000;102:1178–1185
  52. Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome (Development and validation of an efficient approach to genotyping in clinical practice). JAMA. 2005;294:2975–2980
  53. Taggart NW, Haglund CM, Tester DJ, et al. Diagnostic miscues in congenital long-QT syndrome. Circulation. 2007;115:2613–2620
  54. Tester DJ, Kopplin LJ, Will ML, et al. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm. 2005;2:1099–1105
  55. Philips KA, Ackerman MJ, Sakiwski J, et al. Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases. Heart Rhythm. 2005;2:1294–1300
  56. Vincent GM, Jaiswal D, Timothy KW. Effects of exercise on heart rate (QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome). Am J Cardiol. 1991;68:498–503
  57. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99:529–533
  58. Napolitano C, Schwartz PJ, Brown AM, et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol. 2000;11:691–696
  59. Hobbs JB, Peterson DR, Moss AJ, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA. 2006;296:1249–1254
  60. Sauer AJ, Moss AJ, McNitt S, et al. Long QT syndrome in adults. J Am Coll Cardiol. 2007;49:329–337
  61. Goldenberg I, Moss AJ, Zareba W. Time-dependent gender differences in the clinical course of patients with the congenital long-QT syndrome. In:  Wang P,  Hsia H,  Al-Ahmad A, et al. editor. Ventricular arrhythmias and sudden cardiac death mechanism. Blackwell Publishing; 2008;
  62. Goldenberg I, Moss AJ, Peterson DL, et al. Risk of aborted cardiac arrest or sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008;(in press)
  63. Goldenberg I, Moss AJ, Bradley J, et al. Long QT after age 40. Circulation. 2008;(in press)
  64. Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998;97:2237–2244
  65. Zareba W, Moss AJ, Locati EH, et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol. 2003;42:103–109
  66. Moss AJ, Shimizu W, Wilde AA, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007;115:2481–2489
  67. Moss AJ, Zareba W, Kaufman ES, et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation. 2002;105:794–799
  68. Schwartz PJ, Spazzolini C, Crotti L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation. 2006;113:783–790
  69. Goldenberg I, Moss AJ, Zareba W, et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol. 2006;17:1169–1171
  70. Kaufman B, McNitt S, Moss AJ, et al. Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm. 2008;5:831–836
  71. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;10389–10395
  72. Bidoggia H, Maciel JP, Capalozza N, et al. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J. 2000;140:678–683
  73. Drici MD, Burklow TR, Haridasse V, et al. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation. 1996;94:1471–1474
  74. Liu XK, Katchman A, Drici MD, et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther. 1998;285:672–679
  75. Boyle MB, MacLusky NJ, Naftolin F, et al. Hormonal regulation of K+-channel messenger RNA in rat myometrium during oestrus cycle and in pregnancy. Nature. 1987;330:373–375
  76. Rashba EJ, Zareba W, Moss AJ, et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome LQTS Investigators. Circulation. 1998;97:451–456
  77. Seth R, Moss AJ, McNitt S, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007;49:1092–1098
  78. Swan H, Viitasalo M, Piippo K, et al. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol. 1999;34:823–829
  79. Kadish AH. The effect of gender on cardiac electrophysiology and arrhythmias. In:  Zipes DP,  Jalife J editor. Cardiac Electrophysiology: From Cell to Bedside. 2nd edition. Philadelphia, PA: WB Saunders Co.; 1995;p. 1268–1275
  80. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23B–25B
  81. Goldenberg I, Mathew J, Moss AJ, et al. Corrected QT variability in serial ECGs in long QT syndrome: the importance of the maximum QTc for risk stratification. J Am Coll Cardiol. 2006;47:1811–1817
  82. Kimbrough J, Moss AJ, Zareba W, et al. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation. 2001;104:557–562
  83. Priori SG, Napolitano C. The long QT syndrome. In:  Gussak I,  Antzelevitch C editor. Cardiac Repolarization. Totowa, NJ: Humana Press; 2003;p. 169–187
  84. Schwartz PJ, Zaza A, Locati E, et al. Stress and sudden death (The case of the long QT syndrome). Circulation. 1991;83(suppl II):II71–II80
  85. Ackerman MJ, Tester DJ, Porter CJ. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc. 1999;74:1088–1094
  86. Moss AJ, Robinson JL, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol. 1999;84:876–879
  87. Crotti L, Lundquist AL, Insolia R, et al. KCNH2-K897T is a genetic modifier of latent congenital long QT syndrome. Circulation. 2005;112:1251–1258
  88. Crotti L, Spazzolini C, Schwartz PJ, et al. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007;116:2366–2375
  89. Brink PA, Crotti L, Corfield VG, et al. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation. 2005;112:2602–2610
  90. Liu J, Goldenberg I, Moss AJ, et al. Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations. Ann Noninvasive Electrocardiol. 2008;(in press)
  91. Bianchi L, Priori SG, Napolitano C, et al. Mechanisms of I(Ks) suppression in LQT1 mutants. Am J Physiol. 2000;279:H3003–H3011
  92. Shalaby FY, Levesque PC, Yang WP, et al. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation. 1997;96:1733–1736
  93. Zareba W, Moss AJ, Sheu G, et al. Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovasc Electrophysiol. 2003;14:1149–1153
  94. Shimizu W, Horie M, Ohno S, et al. Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol. 2004;44:117–125
  95. January CT, Gong Q, Zhou Z. Long-QT syndrome: cellular basis and arrhythmia mechanism in LQT2. J Cardiovasc Electrophysiol. 2000;11:1413–1418
  96. Akhavan A, Atanasiu R, Noguchi T, et al. Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localization. J Cell Sci. 2005;118:2803–2812
  97. Cui J, Kagan A, Qin D, et al. Analysis of the cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE2. J Biol Chem. 2001;276:17244–17251
  98. Chen J, Zou A, Splawski I, et al. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem. 1999;274:10113–10118
  99. Groh WJ, Silka MJ, Oliver RP, et al. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996;78:703–706
  100. Zareba W, Moss AJ, Daubert JP, et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003;14:337–341
  101. Zareba W, Moss AJ, Daubert JP, et al. Arrhythmic events in LQTS patients with implantable cardioverter defibrillators. Heart Rhythm Society Suppl. 2004;1:532;(abstract)
  102. Berul CI, Triedman JK, Forbess J, et al. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol. 2001;241789-94
  103. Stephenson EA, Batra AS, Knilans TK, et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006;17:41–46
  104. Molina JE, Benditt DJ. An epicardial subxiphoid implantable defibrillator lead: superior effectiveness after failure of standard implants. Pacing Clin Electrophysiol. 2004;27:1500–1506
  105. Goldenberg I, Moss AJ, Maron BJ, et al. Cost effectiveness of implanted defibrillators in young people with Inherited cardiac arrhythmias. Ann Nonivas Cardiol. 2005;4:67–83
  106. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353:1471–1480
  107. Zwanziger J, Hall WJ, Dick AW, et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006;47:2310–2318
  108. Bennett PB, Yazawa K, Makita N, et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683–685
  109. Stramba-Badiale M, Priori SG, Napolitano C, et al. Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep?. Ital Heart J. 2000;1:323–328
  110. Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations on the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate (Implications for gene-specific therapy). Circulation. 1995;92:3381–3386
  111. Windle R, Geletka RC, Moss AJ, et al. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A: DeltaKPQ mutation. Ann Noninvasive Electrocardiol. 2001;6:153–158
  112. Wu L, Shryock JC, Song Y, et al. Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT 1. J Pharmacol Exp Ther. 2004;310:599–605
  113. Moss AJ, Zareba W, Schwarz KQ, et al. Ranolazine shortens repolarization in patients with sustained inward sodium current due to Type-3 long QT syndrome. J Cardiovasc Electrophysiol. 2008;(in press)

 The authors have no conflicts of interest to disclose.

PII: S0146-2806(08)00123-0

doi: 10.1016/j.cpcardiol.2008.07.002

Current Problems in Cardiology
Volume 33, Issue 11 , Pages 629-694 , November 2008

Article Tools

* Image Usage & Resolution